Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Siltuximab plus VMP in Previously Untreated Multiple Myeloma
NCT00911859Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2009
- Primary completion
- Apr 2013
- Modality
- Monoclonal Antibodies
- Countries
- 11
01
Overview
A Phase 2 trial of siltuximab in multiple myeloma (MM), sponsored by Janssen Pharmaceutical. Started Jun 2009; status: completed.
02
Drugs
siltuximab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00911859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911859.